Edit Entry | Edit CV

Kevin F Kwaku, MD, PhD

Title(s)
Assistant Professor of Medicine

Additional Titles/Positions/Affiliations
Director of Cardiac Electrophysiology

Department(s)
Medicine

Education
BSc (Physiology) McGill University, Montreal
MPhil (Pharmacology) Columbia University, New York City
PhD (Pharmacology) Columbia University, New York City
MD (Medicine) Columbia University, New York City
Residency, Massachusetts General Hospital, Boston
Cardiology & EP Fellowships BIDMC, Boston

Programs
Heart and Vascular Research Center

Websites
https://www.dartmouth-hitchcock.org/findaprovider/provider/2350

Academic Analytics
View Profile

Contact Information

Email: Kevin.F.Kwaku@Dartmouth.edu

Assistant: Josette Hall
Asst. Phone: 603-650-4950
Asst. Email: josette.m.hall@hitchcock.org


Professional Interests

Dr. Kwaku is a clinical and translational cardiac electrophysiologist. Clinical and research interests include the development and validation of novel pacing, defibrillation and ablation technologies and strategies to achieve safe and efficacious therapy of cardiac arrhythmias in patients.


Selected Publications

 

Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics.
Goodman SG, Roy D, Pollack CV Jr, Leblanc K, Kwaku KF, Barnes GD, Bonaca MP, True Hills M, Campello E, Fanikos J, Connors JM, Weitz JI
Crit Pathw Cardiol. 2024 Feb 21; doi: 10.1097/HPC.0000000000000351. Epub 2024 Feb 21.
PMID: 38381695

Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes.
Kiernan K, Dodge SE, Kwaku KF, Jackson LR 2nd, Zeitler EP
Heart Rhythm O2. 2022 Dec;3(6Part B):807-816. doi: 10.1016/j.hroo.2022.09.003. Epub 2022 Dec 16.
PMID: 36589011

Keeping the Heartbeat Off-Target in Cancer Therapy.
Starobin BN, Kwaku KF
JAMA Oncol. 2022 Nov 1;8(11):1566-1568. doi: 10.1001/jamaoncol.2022.4106.
PMID: 36136318

Which Patients Benefit Most From Primary Prevention ICDs?: A Call for More Nuanced Risk Stratification.
Kwaku KF, Bunch TJ
JACC Clin Electrophysiol. 2022 Jan;8(1):12-14. doi: 10.1016/j.jacep.2021.11.005.
PMID: 35057976

A Pause for Pot.
Ambrus DB, Ghanta K, Kwaku KF
Am J Med. 2020 Dec;133(12):e690-e692. doi: 10.1016/j.amjmed.2020.03.022. Epub 2020 Apr 9.
PMID: 32277886

Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.
Gupta N, Kiley ML, Anthony F, Young C, Brar S, Kwaku K
J Am Heart Assoc. 2016 Mar 9;5(3):e002798. doi: 10.1161/JAHA.115.002798. Epub 2016 Mar 9.
PMID: 26961369

Vasculitis presenting with ventricular tachycardia.
Tung R, Rahimi AR, Gelfand EV, Kwaku KF
J Rheumatol. 2009 Sep;36(9):2127-9. doi: 10.3899/jrheum.081254.
PMID: 19738228

Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heart.
Kumar K, Nearing BD, Bartoli CR, Kwaku KF, Belardinelli L, Verrier RL
J Cardiovasc Electrophysiol. 2008 Oct;19(10):1073-9. doi: 10.1111/j.1540-8167.2008.01204.x. Epub 2008 May 9.
PMID: 18479333

Treatment options for patients with coronary artery disease identified as high risk by T-wave alternans testing.
Kumar K, Kwaku KF, Verrier RL
Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):39-48.
PMID: 18325306

The atrial neural network: Ablation minefield or strategic target?
Kwaku KF, Verrier RL
Heart Rhythm. 2007 Jan;4(1):64-5. Epub 2006 Oct 13.
PMID: 17198992

View more publications on PubMed